The global insulin market was valued at approximately USD 20.35 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 1.5% from 2022 to 2030. This growth is primarily driven by factors such as the rising incidence of diabetes and advancements in insulin formulations. However, the increasing use of alternative treatments, such as GLP-1 receptor agonists (RAs) for...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian